2 purified by centrifugation with methanol three times and dried in a vacuum oven at 80°C overnight to yield original CNDs. For surface modification, 4-octyloxyaniline (1.1 g, 5 mmol) was added to the original CNDs (15 mg) dissolved in toluene (3 mL). The solution was heated at 100°C for 12 h with vigorous stirring. After cooling to room temperature, the remaining solid was dissolved in toluene (3 mL) and then dialyzed against toluene for at least 3 days by using Spectra/Por Biotech Cellulose Ester dialysis tubes (100-500 Da). The solution was evaporated in a rotary evaporator to yield organic-soluble DC-CNDs. To control the surface modification degree, the amount of 4-octyloxyaniline was varied from 0.1 to 5 mmol.
Preparation of PSMA-encapsulated DC-CNDs (DC-CNDs@PSMA).
For the polymer encapsulation, DC-CNDs (2 mg) and poly(styrene-co-maleic anhydride) (PSMA, 10 mg) were added to tetrahydrofuran (THF, 5 mL). After sonication for 1 h, 1 mL of aliquot was added to a mixture of ethylenediamine (10 L) and water (2 mL). After 1 min, the mixture was mildly heated (60°C) to evaporate THF and dialyzed against water for at least 24 h to prepare DC-CNDs@PSMA. The polymer encapsulation process could be conducted with the same volume of ethanolamine instead of ethylenediamine.
Characterization of DC-CNDs. Transmission electron microscopy (TEM) was performed by using Jeol JEM-2200FS equipped with a Cs corrector. X-ray photoelectron spectroscopy (XPS) was performed by using an Escalab 250 spectrometer with an Al X-ray source (1486.6 eV).
13 C nuclear magnetic resonance (NMR) spectra of CND and DC-CND dissolved in CDCl 3 and 1 H NMR spectrum of DC-CNDs@PSMA dissolved in D 2 O were recorded on a Bruker DRX600 spectrometer (600 MHz). Fourier-transform infrared (FT-IR) spectroscopy were recorded on a Nicolet iS50 FT-IR spectrometer. UV-vis absorption and photoluminescence (PL) spectroscopy were performed with 10 mm × 10 mm QS-grade quartz cuvettes (Hellma Analytics 111-QS). The light absorption spectra were recorded on a Scinco S-3100 spectrophotometer. The PL spectra were recorded on a Jasco FP-8500 fluorometer.
The quantum yield was measured with 2 mm × 10 mm QS-grade quartz cuvettes (Jasco Parts
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Center 6808-H250A). The absolute quantum yields were recorded on a Jasco FP-8500 fluorometer equipped with a 100 mm integrating sphere setup (ILF-835) and calculated by using Jasco Spectra Manager II Software. [1] The transient absorption spectroscopy was performed by using a visible Helios system (Ultrafast systems) having a 1 kHz femtosecond Ti:sapphire laser system (Libra) with 780 nm center wavelength and 80 fs pulse duration. The In vivo acute toxicity test of DC-CNDs@PSMA. After optical imaging for 48 h, the animals were sacrificed to collect the major organs and blood to carry out the preliminary acute toxicity test. The major organs of lung, liver, kidney and spleen were fixed in 4%
paraformaldehyde, embedded in paraffin, sectioned, and stained with hematoxylin and eosin 5 (H&E). The blood chemistry was analyzed using a chemistry analyzer (BS-380, Mindray
Medical International Limited, Shenzhen, China).
Preparation of optogenetic cell line. HEK293T cells were transfected using a DNA plasmid of pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA to express channelrhodopsin-2 (ChR2) as described elsewhere. [2] HEK293T cells were cultured in high glucose DMEM supplemented with 10 vol% FBS without antibiotic-antimycotic solution.
The cells were suspended at a concentration of 1 × 10 5 cellsmL -1 in the medium and 300 μL 
